GlaxoSmithKline and Verily Life Sciences £540 million Galvani Bioelectronics joint venture

1/8/2016
Joint venture

£ 540 million

$ 718.184 million

Completed

1/8/2016


Overview:

  • GlaxoSmithKline and Verily Life Sciences, owned by Google holding company Alphabet, have formed a £540 million joint venture.
  • The project will consist of the creation of a new company Galvani Bioelectronics (to be based in Hertfordshire, UK), that will research ways of fighting disease through electronic implants.
  • GSK will own 55% of the new company and Verily 45%.

Sam Duke - Editor

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in